Androgen receptor pathway inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Androgen receptor pathway inhibitors, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response [Phase 3]